Sunitinib induces hypothyroidism with a markedly reduced vascularity

Thyroid

Volumn 20, Issue 3, 2010, Pages 323-326

  Makita, Noriko ^a   Miyakawa, Megumi ^b   Fujita, Toshiro ^a   Iiri, Taroh ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Toranomon Endocrine Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; SUNITINIB; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE; THYROTROPIN;

ADULT; ARTICLE; ATROPHY; CANCER CHEMOTHERAPY; CASE REPORT; COLOR ULTRASOUND FLOWMETRY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; KIDNEY CARCINOMA; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; THYROID FUNCTION; VASCULARIZATION;

ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; FEMALE; HUMANS; HYPOTHYROIDISM; INDOLES; KIDNEY NEOPLASMS; MIDDLE AGED; ORGAN SIZE; PYRROLES; THYROID GLAND;

EID: 77649310826     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2009.0414     Document Type: Article

References (17)

1. Torino F, Corsello SM, Longo R, Barnabei A, Gasparini G 2009 Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy. Nat Rev Clin Oncol 6:219-228.
2. Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, Oudard S, Negrier S, Szczylik C, Kim ST, Chen I, Bycott PW, Baum CM, Figlin RA 2007 Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356:115-124.
3. Bogazzi F, Bartalena L, Brogioni S, Burelli A, Manetti L, Tanda ML, Gasperi M, Martino E 1999 Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow doppler sonography. Eur J Endocrinol Eur Fed Endocr Soc 140:452-456.
4. Mannavola D, Coco P, Vannucchi G, Bertuelli R, Carletto M, Casali PG, Beck-Peccoz P, Fugazzola L 2007 A novel tyrosinekinase selective inhibitor, sunitinib, induces transient hypothyroidism by blocking iodine uptake. J Clin Endocrinol Metab 92:3531-3534.
5. Grossmann M, Premaratne E, Desai J, Davis ID 2008 Thyrotoxicosis during sunitinib treatment for renal cell carcinoma. Clin Endocrinol (Oxf) 69:669-672.
6. Wolter P, Stefan C, Decallonne B, Dumez H, Bex M, Carmeliet P, Schoffski P 2008 The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation. Br J Cancer 99:448-454.
7. Desai J, Yassa L, Marqusee E, George S, Frates MC, Chen MH, Morgan JA, Dychter SS, Larsen PR, Demetri GD, Alexander EK 2006 Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors. Ann Intern Med 145:660-664.
8. Wong E, Rosen LS, Mulay M, Vanvugt A, Dinolfo M, Tomoda C, Sugawara M, Hershman JM 2007 Sunitinib induces hypothyroidism in advanced cancer patients and may inhibit thyroid peroxidase activity. Thyroid 17:351-355.
9. Salem AK, Fenton MS, Marion KM, Hershman JM 2008 Effect of sunitinib on growth and function of FRTL-5 thyroid cells. Thyroid 18:631-635.
10. Ramsden JD 2000 Angiogenesis in the thyroid gland. J Endocrinol 166:475-480.
11. Viglietto G, Romano A, Manzo G, Chiappetta G, Paoletti I, Califano D, Galati MG, Mauriello V, Bruni P, Lago CT, Fusco A, Persico MG 1997 Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1=KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization. Oncogene 15:2687-2698.
12. Wang JF, Milosveski V, Schramek C, Fong GH, Becks GP, Hill DJ 1998 Presence and possible role of vascular endothelial growth factor in thyroid cell growth and function. J Endocrinol 157:5-12.
13. Katoh R 2003 Angiogenesis in endocrine glands: special reference to the expression of vascular endothelial growth factor. Microsc Res Tech 60:181-185.
14. Ellis LM, Hicklin DJ 2008 VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat Rev Cancer 8:579-591.
15. Rini BI, Tamaskar I, Shaheen P, Salas R, Garcia J, Wood L, Reddy S, Dreicer R, Bukowski RM 2007 Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib. J Natl Cancer Inst 99:81-83.
16. Kamba T, Tam BY, Hashizume H, Haskell A, Sennino B, Mancuso MR, Norberg SM, O'Brien SM, Davis RB, Gowen LC, Anderson KD, Thurston G, Joho S, Springer ML, Kuo CJ, McDonald DM 2006 VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol 290:H560-H576.
17. Faris JE, Moore AF, Daniels GH 2007 Sunitinib (sutent)-induced thyrotoxicosis due to destructive thyroiditis: a case report. Thyroid 17:1147-1149.